文献速递关节外科

全国范围内常见术前预防性抗生素的病原体敏感性模式:我们到底覆盖了什么?

Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
PubMed 文献 · J Arthroplasty · 2019-01-17

该研究通过查阅公开的州级和区域性抗菌谱数据,评估了常见革兰阳性感染病原体对苯唑西林(作为头孢唑林的替代指标)、克林霉素和万古霉素的敏感性。结果显示苯唑西林对甲氧西林敏感金黄色葡萄球菌(MSSA)敏感性达99.2±4.8%,但对凝固酶阴性葡萄球菌(CNS)和表皮葡萄球菌仅分别为44.5±13.7%和30.6±10.5%;万古霉素对所有菌种敏感性均接近99%以上;克林霉素对MSSA敏感性为75.8±8.4%,显著低于苯唑西林和万古霉素(P<.0001)。作者认为克林霉素的全国敏感性模式仅限于MSSA,可能不适合作为预防性抗生素,而头孢唑林对MSSA仍具有极好的覆盖。

要点

  • 苯唑西林(头孢唑林替代指标)对MSSA敏感性为99.2±4.8%,对CNS仅44.5±13.7%。
  • 万古霉素对MSSA、MRSA、CNS和表皮葡萄球菌敏感性均达99.6%以上。
  • 克林霉素对MSSA敏感性75.8±8.4%,显著低于苯唑西林和万古霉素(P<.0001)。

核心结论

  • 全国克林霉素敏感性模式仅限于MSSA,可能不具备适合用作预防性抗生素的最佳敏感性特征;头孢唑林对MSSA仍具有极好的覆盖。

研究设计与样本

  • 研究评估了公开可获取的区域和州级抗菌谱中常见革兰阳性感染病原体的抗生素敏感性模式,记录了每种抗菌谱检测的分离株数量及对苯唑西林、克林霉素和万古霉素敏感的菌株百分比,苯唑西林在抗菌谱中用作头孢唑林的替代指标,并进行了抗生素敏感性比较。

主要发现

  • 共审查了7个州级和38个区域性抗菌谱。
  • 苯唑西林对MSSA分离株的敏感比例为99.2±4.8%,对MRSA为0±0%,对CNS为44.5±13.7%,对表皮葡萄球菌为30.6±10.5%。
  • 克林霉素对MSSA的敏感比例为75.8±8.4%,对MRSA为60.2±13.2%,对CNS为60.3±11.4%,对表皮葡萄球菌为56.2±6.5%。
  • 万古霉素对MSSA的敏感比例为99.9±0.4%,对MRSA为99.8±0.4%,对CNS为99.8±0.5%,对表皮葡萄球菌为99.6±0.7%。
  • 克林霉素对MSSA分离株的敏感性显著低于苯唑西林和万古霉素(P<.0001);苯唑西林对CNS、表皮葡萄球菌和MRSA分离株的敏感性显著低于克林霉素和万古霉素(P<.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many periprosthetic joint infections (PJIs) are caused by organisms not susceptible to first-generation cephalosporins. We sought to evaluate the national susceptibility patterns of organisms to cefazolin and, or oxacillin, clindamycin, and vancomycin using antibiogram data. METHODS: Publically available regional and state antibiograms were evaluated for antibiotic susceptibility patterns to commonly infecting gram-positive organisms. The number of isolates tested in each antibiogram and percent of strains susceptible to oxacillin, clindamycin, and vancomycin were recorded. Oxacillin is used as a surrogate to cefazolin in antibiograms. A comparison of antibiotic susceptibilities was performed. RESULTS: Seven state and 38 regional antibiograms were reviewed. Oxacillin was a sensitive antibiotic in 99.2 ± 4.8% of methicillin-sensitive Staphylococcus aureus (MSSA) isolates, 0 ± 0% of methicillin-resistant Staphylococcus aureus (MRSA) isolates, 44.5 ± 13.7% of coagulase-negative staphylococcus organism isolates (CNS), and 30.6 ± 10.5% of Staphylococcus epidermidis isolates. Clindamycin was a sensitive antibiotic in 75.8 ± 8.4% of MSSA isolates, 60.2 ± 13.2% of MRSA isolates, 60.3 ± 11.4% of CNS isolates, and 56.2 ± 6.5% of S epidermidis isolates. Vancomycin was a sensitive antibiotic in 99.9 ± 0.4% of MSSA isolates, 99.8 ± 0.4% of MRSA isolates, 99.8 ± 0.5% of CNS isolates, and 99.6 ± 0.7% of S epidermidis isolates. Clindamycin was significantly less sensitive in MSSA isolates as compared with oxacillin and vancomycin (P < .0001). Oxacillin was significantly less sensitive in CNS, S epidermidis, and MRSA isolates as compared with clindamycin and vancomycin (P < .0001). CONCLUSION: The national clindamycin susceptibility pattern is limited to MSSA and may not have an optimal susceptibility profile suitable for use as a prophylactic antibiotic. Cefazolin continues to have excellent coverage against MSSA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Nodzo SR, Boyle KK, Frisch NB, et al. Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering? J Arthroplasty. 2019. PMID: 30745218. doi:10.1016/j.arth.2019.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。